1996 (5 POSTS)

Choksi NY, Hussain A, Booth RG. 1996. 2-Phenylaminoadenosine stimulates adenylyl cyclase activity and dopamine biosynthesis through an A2 receptor mediated mechanism. Brain Res 761:151–155, DOI: 10.1016/s0006-8993(97)00445-9.

View Abstract

Lea IA, Richardson RT, Widgren EE, O’Rand MG. 1996. Cloning and sequencing of cDNAs encoding the human sperm protein, Sp17. Biochim Biophys Acta 1307(3):263–266.

View Abstract

1995 (4 POSTS)

Huber KM, Mauk MD, Thompson CM, and Kelly PT. 1995. A critical period of protein kinase activity after tetanic stimulation is required for the induction of long-term potentiation. Learning & Memory. 2, 81–100.

Perry CS, Liu XL, Lund LG, and Kehrer JP. 1995. Differential toxicities of cyclophosphamide and its glutathione metabolites to A549 cells. Toxicol in Vitro 9:21-26.

Norton JN, Rylander LA, Richards JL. 1995. In vitro oral mucosa irritation testing with human cell cultures. Toxicol In Vitro 9(1):67–74.

View Abstract

Vater ST, Velazquez SF, Cogliano VJ. 1995. A case study of cancer data set combinations for PCBs. Regul Toxicol Pharmacol 22:2–10.

View Abstract

1994 (4 POSTS)

Gargas M, Norton R, Harris MA, Paustenbach D, and Finley B. 1994. Urinary excretion of chromium following ingestion of chromite ore processing residue in humans: implications for biomonitoring. Risk Anal. 14(6):1019-1024.

Haws LC, Jackson BA, Turnbull D, and Dressler WE. 1994. Two approaches for assessing human cancer risk from disperse blue 1. Reg Toxicol Pharmacol. 19:80-96.

Rish W. 1994. SEC Initiatives in environmental disclosure: How can environmental liability be estimated? Ohio Environmental Law Letter 4(6):3–4.

Sahl JD, Kelsh MA, Smith RW, Aseltine DA. 1994. Exposure to 60 Hz magnetic fields in the electric utility work environment. Bioelectromagnetics 15(1):21-32. https://doi.org/10.1002/bem.2250150107

View Abstract

1993 (5 POSTS)

Copeland TL, Paustenbach DJ, Harris MA, and Otani J. 1993. Comparing the results of a Monte Carlo analysis with EPA’s reasonable maximum exposed individual (RMEI): a case study of a former wood treatment site. Reg Toxicol Pharmacol. 18:275-312.

Harris, MA, Zacharewski T, and Safe S. 1993. Comparative potencies of Aroclors 1232, 1248, 1254, and 1260 in male wistar rats—Assessment of the toxic equivalency factor (TEF) approach for polychlorinated biphenyls (PCBs). Fund Appl Toxicol. 20:456-463.

Steup DR, Hall P, McMillan DA, Sipes IG. 1993. Time course of hepatic injury and recovery following coadministration of carbon tetrachloride and trichloroethylene in Fischer-344 rats. Toxicol Pathol 21:327–334.

View Abstract

Vater ST, McGinnis PM, Schoeny RS, Velazquez SF. 1993. Biological considerations for combining carcinogenicity data for quantitative risk assessment. Regul Toxicol Pharmacol 18(3):403–418.

View Abstract

Sahl JD, Kelsh MA, Greenland S. 1993. Cohort and nested case-control studies of hematopoietic cancers and brain cancer among electric utility workers. Epidemiology 4(2):104-114. https://doi.org/10.1097/00001648-199303000-00005

View Abstract

1992 (3 POSTS)

Wenning RJ, Harris MA, Ungs MJ, Paustenbach DJ, and Bedbury H. 1992. Chemometric comparison of polychlorinated dibenzo-p-dioxin and dibenzofuran residues in surficial sediments from Newark Bay, New Jersey and other industrialized waterways. Arch Environ Contam Toxicol. 22:397-413.

Wenning RJ, Harris MA, Paustenbach DJ, and Bedbury H. 1992. Potential sources of 1,2,8,9-tetrachlorodibenzo-p-dioxin in the aquatic environment. Ecotoxicol Environ Safety. 23(2):133-146.

Zacharewski T, Harris MA, Biegel L, Morrison V, Merchant M, and Safe S. 1992. 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as an antiestrogen in human and rodent cancer cell lines: evidence for the role of the Ah receptor. Toxicol Appl Pharmacol. 113:311-318.

1991 (12 POSTS)

Couture-Haws L, Harris MW, Lockhart AC, and Birnbaum LS. 1991. Evaluation of the persistence of hydronephrosis induced in mice following in uteri and/or lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Appl Pharmacol. 107:402-412.

Couture-Haws L, Harris MW, McDonald MM, Lockhart AC,  Birnbaum LS. 1991. Hydronephrosis in mice exposed to TCDD-contaminated breast milk: Identification of the peak period of sensitivity and assessment of potential recovery. Toxicol Appl Pharmacol 107:413-428.